Ea Mulligan1, Hayley Messenger. 1. School of Law, Flinders University of South Australia, Adelaide, South Australia. ea.mulligan@flinders.edu.au
Abstract
BACKGROUND: Mifepristone has recently become available in Australia but its use is restricted. OBJECTIVE: To describe the use of mifepristone in South Australia in the period 2009-2010 and to explore options that may become available to general practitioners. DISCUSSION: Mifepristone has been added to regimens for early and second trimester abortions - both medical and surgical abortions. It has been most commonly used in early medical abortions. In this audit the complication rates of early medical abortion with mifepristone compared favourably to early surgical abortion. There are implications in service delivery of early medical abortion compared to early surgical abortion.
BACKGROUND:Mifepristone has recently become available in Australia but its use is restricted. OBJECTIVE: To describe the use of mifepristone in South Australia in the period 2009-2010 and to explore options that may become available to general practitioners. DISCUSSION: Mifepristone has been added to regimens for early and second trimester abortions - both medical and surgical abortions. It has been most commonly used in early medical abortions. In this audit the complication rates of early medical abortion with mifepristone compared favourably to early surgical abortion. There are implications in service delivery of early medical abortion compared to early surgical abortion.